Parallel neurodegenerative phenotypes in sporadic Parkinson's disease fibroblasts and midbrain dopamine neurons

被引:7
|
作者
Corenblum, M. J. [1 ]
McRobbie-Johnson, A. [2 ]
Carruth, E. [3 ]
Bernard, K. [2 ]
Luo, M. [4 ]
Mandarino, L. J. [4 ]
Peterson, S. [5 ]
Sans-Fuentes, M. A. [5 ]
Billheimer, D. [5 ]
Maley, T. [2 ]
Eggers, E. D. [6 ,7 ]
Madhavan, L. [1 ,8 ,9 ,10 ]
机构
[1] Univ Arizona, Dept Neurol, Tucson, AZ USA
[2] Univ Arizona, Physiol Sci Grad Program, Tucson, AZ USA
[3] Univ Arizona, Physiol Undergraduate Program, Tucson, AZ USA
[4] Univ Arizona, Dept Med, Tucson, AZ USA
[5] Univ Arizona, BIO5 Inst, Stat Consulting Lab, Tucson, AZ USA
[6] Univ Arizona, Dept Physiol, Tucson, AZ USA
[7] Univ Arizona, Dept Biomed Engn, Tucson, AZ USA
[8] Univ Arizona, Evelyn McKnight Brain Inst, Tucson, AZ USA
[9] Univ Arizona, BIO5 Inst, Tucson, AZ USA
[10] Univ Arizona, Dept Neurol, 1501,N Campbell Ave, Tucson, AZ 85724 USA
关键词
Skin fibroblasts; Human Induced Pluripotent Stem Cells; Midbrain Dopamine Neurons; Aging; Parkinson 's disease; Mitochondrial Dysfunction; ALPHA-SYNUCLEIN; HUMAN ES; CELLS; MITOCHONDRIA;
D O I
10.1016/j.pneurobio.2023.102501
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Understanding the mechanisms causing Parkinson's disease (PD) is vital to the development of much needed early diagnostics and therapeutics for this debilitating condition. Here, we report cellular and molecular alterations in skin fibroblasts of late-onset sporadic PD subjects, that were recapitulated in matched induced pluripotent stem cell (iPSC)-derived midbrain dopamine (DA) neurons, reprogrammed from the same fibroblasts. Specific changes in growth, morphology, reactive oxygen species levels, mitochondrial function, and autophagy, were seen in both the PD fibroblasts and DA neurons, as compared to their respective controls. Additionally, significant alterations in alpha synuclein expression and electrical activity were also noted in the PD DA neurons. Interestingly, although the fibroblast and neuronal phenotypes were similar to each other, they differed in their nature and scale. Furthermore, statistical analysis revealed potential novel associations between various clinical measures of the PD subjects and the different fibroblast and neuronal data. In essence, these findings encapsulate spontaneous, in-tandem, disease-related phenotypes in both sporadic PD fibroblasts and iPSC-based DA neurons, from the same patient, and generates an innovative model to investigate PD mechanisms with a view towards rational disease stratification and precision treatments.
引用
收藏
页数:20
相关论文
共 50 条
  • [41] Pathological features of iPSC-derived midbrain dopaminergic neurons of familial Parkinson's disease
    Frattini, E.
    Compagnoni, G. Monzio
    Salani, S.
    Bresolin, N.
    Comi, G. P.
    Corti, S.
    Di Fonzo, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 395 - 395
  • [42] Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson's disease in midbrain dopaminergic neurons
    Virdi, Gurvir S.
    Choi, Minee L.
    Evans, James R.
    Yao, Zhi
    Athauda, Dilan
    Strohbuecker, Stephanie
    Nirujogi, Raja S.
    Wernick, Anna, I
    Pelegrina-Hidalgo, Noelia
    Leighton, Craig
    Saleeb, Rebecca S.
    Kopach, Olga
    Alrashidi, Haya
    Melandri, Daniela
    Perez-Lloret, Jimena
    Angelova, Plamena R.
    Sylantyev, Sergiy
    Eaton, Simon
    Heales, Simon
    Rusakov, Dmitri A.
    Alessi, Dario R.
    Kunath, Tilo
    Horrocks, Mathew H.
    Abramov, Andrey Y.
    Patani, Rickie
    Gandhi, Sonia
    NPJ PARKINSONS DISEASE, 2022, 8 (01)
  • [43] Parkinson's disease candidate gene prioritization based on expression profile of midbrain dopaminergic neurons
    Shahrooz Vahedi
    Mehrnoosh Rajabian
    Arman Misaghian
    Daniel Grbec
    Horst H Simon
    Kambiz N Alavian
    Journal of Biomedical Science, 17
  • [44] Parkinson's disease candidate gene prioritization based on expression profile of midbrain dopaminergic neurons
    Vahedi, Shahrooz
    Rajabian, Mehrnoosh
    Misaghian, Arman
    Grbec, Daniel
    Simon, Horst H.
    Alavian, Kambiz N.
    JOURNAL OF BIOMEDICAL SCIENCE, 2010, 17
  • [45] Activin A Protects Midbrain Neurons in the 6-Hydroxydopamine Mouse Model of Parkinson's Disease
    Stayte, Sandy
    Rentsch, Peggy
    Li, Kong M.
    Vissel, Bryce
    PLOS ONE, 2015, 10 (04):
  • [46] Synaptic reintegration of grafted dopamine neurons in mouse model for Parkinson's disease
    Licznerski, P.
    Hallett, P. J.
    Isacson, O.
    CELL TRANSPLANTATION, 2008, 17 (04) : 471 - 471
  • [47] Protective effect of Aloperine on Dopamine Neurons of Parkinson's Disease by Activating Autophagy
    Jing, Huang
    Maodong, Wu
    Zhenjie, Sun
    Aimin, Li
    LATIN AMERICAN JOURNAL OF PHARMACY, 2020, 39 (11): : 2176 - 2182
  • [48] Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease
    Lindvall, Olle
    Kokaia, Zaal
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2009, 30 (05) : 260 - 267
  • [49] A Peek into Parkinson's Disease Progression through Human Dopamine Neurons in a Dish
    Yang, Nan
    Yue, Zhenyu
    TRENDS IN NEUROSCIENCES, 2018, 41 (02) : 74 - 76
  • [50] A specific survival response in dopamine neurons at most risk in Parkinson's disease
    Murase, Sachiko
    McKay, Ronald D.
    JOURNAL OF NEUROSCIENCE, 2006, 26 (38): : 9750 - 9760